Neeloffer Mookherjee Selected Research

IDR 1002

1/2021	Disrupting Tryptophan in the Central Hydrophobic Region Selectively Mitigates Immunomodulatory Activities of the Innate Defence Regulator Peptide IDR-1002.
1/2020	Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation.
10/2018	Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness.
8/2011	Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neeloffer Mookherjee Research Topics

Disease

17	Inflammation (Inflammations) 01/2022 - 02/2006
14	Infections 01/2020 - 01/2006
7	Asthma (Bronchial Asthma) 01/2022 - 01/2016
7	Rheumatoid Arthritis 11/2020 - 09/2011
5	Arthritis (Polyarthritis) 01/2021 - 08/2011
4	Experimental Arthritis 01/2021 - 02/2014
4	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2012
3	Respiratory Hypersensitivity 01/2021 - 01/2016
3	Sepsis (Septicemia) 08/2007 - 01/2006
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 12/2020
2	Pain (Aches) 01/2021 - 01/2017
2	Tuberculosis (Tuberculoses) 10/2019 - 01/2015
2	Bacterial Infections (Bacterial Infection) 08/2009 - 08/2007
1	Atherosclerosis 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Muscle Cramp (Cramp) 01/2020
1	Necrosis 10/2018
1	Disease Progression 01/2017
1	Pneumonia (Pneumonitis) 01/2016
1	Hyperplasia 01/2016
1	Septic Shock (Toxic Shock Syndrome) 05/2015
1	Autoimmune Diseases (Autoimmune Disease) 12/2013
1	Chronic Disease (Chronic Diseases) 01/2012
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 08/2007
1	Endotoxemia 02/2006

Drug/Important Bio-Agent (IBA)

16	Peptides (Polypeptides)IBA 01/2021 - 01/2006
7	CathelicidinsIBA 01/2020 - 02/2006
6	CytokinesIBA 10/2019 - 08/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2006
4	Biological ProductsIBA 01/2022 - 07/2016
4	IDR 1002IBA 01/2021 - 08/2011
4	Vitamin D FDA LinkGeneric 01/2021 - 01/2012
3	AllergensIBA 01/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Interleukin-33IBA 12/2020 - 01/2016
3	Antimicrobial PeptidesIBA 01/2020 - 08/2018
3	Antimicrobial Cationic PeptidesIBA 01/2020 - 02/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2015 - 01/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
2	ProteomeIBA 01/2022 - 01/2021
2	AcidsIBA 01/2021 - 08/2011
2	SteroidsIBA 01/2021 - 10/2018
2	DefensinsIBA 01/2020 - 10/2019
2	hydroxide ionIBA 01/2019 - 01/2015
2	InterleukinsIBA 10/2018 - 08/2011
2	MicroRNAs (MicroRNA)IBA 11/2017 - 12/2013
2	EndotoxinsIBA 05/2015 - 09/2014
1	Apolipoproteins B (ApoB)IBA 01/2022
1	Chemokine CX3CL1IBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	CurcuminIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 11/2020
1	LipopolysaccharidesIBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 10/2018
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	EnzymesIBA 01/2017
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2017
1	AntioxidantsIBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Interleukin-13IBA 01/2016
1	CollagenIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	AminoglycosidesIBA 05/2015
1	Dual Specificity Phosphatase 1IBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Vitamin D-Binding ProteinIBA 01/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012
1	Vancomycin FDA LinkGeneric 04/2007
1	Toll-Like Receptor AgonistsIBA 02/2006
1	ChemokinesIBA 02/2006
1	NF-kappa B (NF-kB)IBA 02/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2006

Therapy/Procedure

6	Therapeutics 01/2022 - 08/2007
1	Immunomodulation 01/2021